Codex DNA - TBIO Net Assets per Single Share

Graphic logo of Telesis Bio, Inc. (TBIO)

The book value per share for Telesis Bio, Inc. (TBIO) on GURU.Markets shows an upward trend, with the indicator reaching -11.66. Despite the growth in capital, Telesis Bio, Inc. (TBIO) is fighting for market share against major players. The stability of the systems is ensured by the California-based synthesizer assembly plant. Business prospects rely on the development of gene therapy and the implementation of the BioXp gold standard in laboratories.

Codex DNA (TBIO) Equity per Share: for the period 04/28/2023 - 10/05/2024
Manufactured products of Telesis Bio Inc.

Investors are assessing the prospects of Telesis Bio, Inc. (TBIO) through the lens of tangible stability, where the book value per share determines the net asset value minus liabilities. Analyzing the book value per share data on GURU.Markets reveals how stable reagent supplies and inventory buffers support the company's solid foundation, transforming Telesis Bio, Inc. (TBIO) into a defensive asset with a low risk of capitalization losses.

Competitor analysis for Telesis Bio, Inc.

Book Value per Share TEM (Tempus AI, Inc.)|QGEN: Net Assets per Share|Net Assets per Single Share IONS|repligen.com (RGEN) - Net Asset Value per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|SRPT - Book Value per Share|Accounting Value per Share Twist Bioscience, Inc. TWST|TXG - Book Price of a Share|Book Value per Share NTLA|STOK (Stoke Corp) - Net Asset Value per Share|Net Assets per Single Share BioLife Solutions, Inc.|Net Assets per Single Share wavelifesciences.com|Maze Therapeutics - Book Value per Share|Net Asset Value per Share SION (Sionna Therapeutics, Inc.)|Net Assets per Single Share PRME|Net Assets per Share Taysha Corp TSHA|Book Value per Share QURE (uniQure N.V.)|MGTX: Net Assets per Share|REGENXBIO - Net Assets per Single Share|Net Assets per Share Solid Biosciences Inc|OCGN - Accounting Value per Share|Accounting Value of a Share PacBio Corp|Book Value per Share Benitec Biopharma Inc. (BNTC)|Net Assets per Single Share designtx.com (DSGN)|Book Value per Share RCKT|4DMT - Net Assets per Share|LXEO (Lexeo) - Net Assets per Single Share|Korro Bio, Inc. (KRRO) - Net Asset Value per Share|Accounting Value per Share Editas Medicine, Inc. EDIT|silence-therapeutics.com (SLN) - Accounting Value of a Share|PRQR: Book Value per Share|Net Assets per Share CDXS|Net Assets per Single Share Sangamo SGMO|Equity per Share nautilus.bio (NAUT)|Metagenomi, Inc. - Book Value per Share|DTIL - Accounting Value per Share|Accounting Value per Share GBIO (Generation Bio Corp)|Boundless Bio Inc. (BOLD) - Net Assets per Share|XCUR - Accounting Value per Share|Imunon (IMNN) - Book Price of a Share|Book Value per Share Phio Pharmaceuticals Corp|Net Assets per Single Share Mustang Bio Corp|RNAZ (TransCode Therapeutics) - Book Value per Share|Net Assets per Share BNGO (bionanogenomics.com)|APDN: Net Assets per Single Share|Net Asset Value per Share bluebird bio, Inc BLUE|ImmunoPrecise (IPA) - Book Value per Share|OMGA: Equity per Share|Net Assets per Single Share Singular Genomics|Regulus Therapeutics, Inc. (RGLS) - Equity per Share|SYRS (Syros) - Book Value per Share|Book Value per Share TRACON Pharmaceuticals, Inc (TCON)|Accounting Value per Share Unity Biotechnology